Interleukin-2, interleukin-15, and their roles in human natural killer cells

被引:252
作者
Becknell, B [1 ]
Caligiuri, MA
机构
[1] Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA
[2] Ohio State Univ, Integrated Biomed Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
[4] Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA
[5] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 86 | 2005年 / 86卷
关键词
D O I
10.1016/S0065-2776(04)86006-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Natural killer (NK) cells are CD56(+)CD3(-) large granular lymphocytes that constitute a key component of the human innate immune response. In addition to their potent cytolytic activity, NK cells elaborate a host of immunoregulatory cytokines and chemokines that play a crucial role in pathogen clearance. Furthermore, interactions between NK and other immune cells are implicated in triggering the adaptive, or antigen-specific, immune response. Interleukin-2 (IL-2) and IL-15 are two distinct cytokines with partially overlapping properties that are implicated in the development, homeostasis, and function of NK cells. This review examines the pervasive effects of IL-2 and IL-15 on NK cell biology, with an emphasis on recent discoveries and lingering challenges in the field.
引用
收藏
页码:209 / 239
页数:31
相关论文
共 111 条
  • [81] Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
    Park, SY
    Saijo, K
    Takahashi, T
    Osawa, M
    Arase, H
    Hirayama, N
    Miyake, K
    Nakauchi, H
    Shirasawa, T
    Saito, T
    [J]. IMMUNITY, 1995, 3 (06) : 771 - 782
  • [82] Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
    Parrish-Novak, J
    Dillon, SR
    Nelson, A
    Hammond, A
    Sprecher, C
    Gross, JA
    Johnston, J
    Madden, K
    Xu, WF
    West, J
    Schrader, S
    Burkhead, S
    Heipel, M
    Brandt, C
    Kuijper, JL
    Kramer, J
    Conklin, D
    Presnell, SR
    Berry, J
    Shiota, F
    Bort, S
    Hambly, K
    Mudri, S
    Clegg, C
    Moore, M
    Grant, FJ
    Lofton-Day, C
    Gilbert, T
    Raymond, F
    Ching, A
    Yao, L
    Smith, D
    Webster, P
    Whitmore, T
    Maurer, M
    Kaushansky, K
    Holly, RD
    Foster, D
    [J]. NATURE, 2000, 408 (6808) : 57 - 63
  • [83] ACTIVATION OF NATURAL-KILLER CELLS VIA THE P75 INTERLEUKIN-2 RECEPTOR
    PHILLIPS, JH
    TAKESHITA, T
    SUGAMURA, K
    LANIER, LL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (01) : 291 - 296
  • [84] ADMINISTRATION OF RECOMBINANT INTERLEUKIN-2 TO MICE ENHANCES PRODUCTION OF HEMATOPOIETIC AND NATURAL-KILLER-CELLS
    PIGUET, PF
    GRAU, G
    IRLE, C
    VASSALLI, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (10) : 1257 - 1261
  • [85] PRODUCTION AND DIFFERENTIATION OF NK LINEAGE CELLS IN LONG-TERM BONE-MARROW CULTURES IN THE ABSENCE OF EXOGENOUS GROWTH-FACTORS
    POLLACK, SB
    TSUJI, J
    ROSSE, C
    [J]. CELLULAR IMMUNOLOGY, 1992, 139 (02) : 352 - 362
  • [86] INTERLEUKIN-2 MEDIATES P72(SYK) ACTIVATION IN PERIPHERAL-BLOOD LYMPHOCYTES
    QIN, SF
    INAZU, T
    YANG, C
    SADA, K
    TANIGUCHI, T
    YAMAMURA, H
    [J]. FEBS LETTERS, 1994, 345 (2-3) : 233 - 236
  • [87] IL-15 is an essential mediator of peripheral NK-cell homeostasis
    Ranson, T
    Vosshenrich, CAJ
    Corcuff, E
    Richard, O
    Müller, W
    Di Santo, JP
    [J]. BLOOD, 2003, 101 (12) : 4887 - 4893
  • [88] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE
    ROSENBERG, SA
    LOTZE, MT
    MUUL, LM
    CHANG, AE
    AVIS, FP
    LEITMAN, S
    LINEHAN, WM
    ROBERTSON, CN
    LEE, RE
    RUBIN, JT
    SEIPP, CA
    SIMPSON, CG
    WHITE, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) : 889 - 897
  • [89] Rosenberg SA, 2000, CANCER J, V6, pS2
  • [90] Rosmaraki EE, 2001, EUR J IMMUNOL, V31, P1900, DOI 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO